We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
27 Nov 20
CX-5461 works to stabilise DNA G-quadruplexes of cancer cells and facilitates disruption of the replication fork in cancer…
27 Oct 20
Bayer will add AskBio’s advanced adeno-associated virus (AAV)-based gene therapy platform to its cell and gene therapy (CGT)…
03 Sep 20
Janssen’s decision is based on results from the interim analyses of the Phase 3 clinical study of Pimodivir…
26 Aug 20
As part of the agreement, Takeda and Engitix will complete validation and preclinical development of new therapeutics for…
20 Aug 20
CARE is a new public-private partnership that brings together scientists from academia, research centres, SMEs, EFPIA member companies…
14 Jul 20
Dr Tim Guilliams, CEO of UK biotech firm Healx, discusses three key ways AI has helped healthcare providers…
12 Jun 20
Corvidia is involved in the research, development and commercialisation of advanced therapies for cardio-renal diseases
Analysts are torn on the potential of remdesivir as a Covid-19 vaccine after Gilead Sciences halted a trial…
17 Apr 20
Convalescent plasma is an antibody-based product, developed from blood donated by people who have recovered from the disease…
Moderna has already given a dose of its potential Covid-19 vaccine to a patient